EFFECTS OF A CANNABINOID ON SPONTANEOUS AND EVOKED NEURONAL-ACTIVITY IN THE SUBSTANTIA-NIGRA PARS RETICULATA

被引：79

作者：

MILLER, AS ^{[1
]}

WALKER, JM ^{[1
]}

机构：

[1] BROWN UNIV,DEPT PSYCHOL,SCHRIER RES LAB,PROVIDENCE,RI 02912

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1995年 / 279卷 / 2-3期

关键词：

BASAL GANGLIA; CANNABINOID; SUBSTANTIA NIGRA; CANNABINOID RECEPTOR; MOTOR SYSTEM; MARIJUANA; TETRAHYDROCANNABINOL; WIN 55,212-2; AMINOALKYLINDOLE;

D O I：

10.1016/0014-2999(95)00151-A

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Single unit electrophysiology was used to explore the role of cannabinoid receptors in the substantia nigra pars reticulata. Intravenous and intraperitoneal injections of the potent and selective synthetic cannabinoid (R)-(+)-[2,3-dihydro-5-methyl-3-[(4-morphorinyl)methyl]pyrrolo[ 1,2,3-de]-1,4-benzoxazin-6-yl](1-naphthalenyl) methanone (WIN 55,212-2) produced modest but significant increases in the spontaneous firing rate of neurons in the substantia nigra pars reticulata. In a second set of experiments, WIN 55,212-2 (up to 1.0 mg/kg i.v.) antagonized the inhibition of firing produced in the substantia nigra pars reticulata by electrical stimulation of the striatum. The pharmacological specificity of this effect was demonstrated using the inactive enantiomer WIN 55,212-3. The possibility that WIN 55,212-2 exerts its effects by regulating gamma-aminobutyric acid (GABA) release from striatonigral fibers was suggested by the observation that bicuculline (up to 0.5 mg/kg i.v.) reversed the effect of striatal stimulation. It thus appears that cannabinoid receptors on striatonigral neuron terminals may regulate movement by disinhibiting the activity of substantia nigra pars reticulata neurons, perhaps by inhibiting the release of GABA into the substantia nigra pars reticulata.

引用

页码：179 / 185

页数：7

共 43 条

[1] Abood, Martin, Neurobiology of marijuana abuse, Trends Pharmacol. Sci., 13, (1992)
[2] Bickford, Hall, The nigral projection to predorsal bundle cells in the superior colliculus of the rat, J. Comp. Neurol., 319, (1992)
[3] Bidaut-Russell, Devane, Howlett, Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain, J. Neurochem., 55, (1990)
[4] Bunney, Walters, Roth, Aghajanian, Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther., 185, (1973)
[5] Compton, Rice, De Costa, Razdan, Melvin, Johnson, Martin, Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities, J. Pharmacol. Exp. Ther., 286, (1993)
[6] Crossman, Walker, Woodruff, Picrotoxin antagonism of γ-aminobutyric acid inhibitory responses and synaptic inhibition in the substantia nigra, Br. J. Pharmacol., 49, (1973)
[7] D'Ambra, Estep, Bell, Eissenstat, Josef, Ward, Haycock, Baizman, Casiano, Beglin, Chippari, Grego, Kullnig, Daley, Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor, J. Med. Chem., 35, (1992)
[8] Deniau, Hammond, Riszk, Feger, Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidence for the existence of branched neurons, Exp. Brain Res., 32, (1978)
[9] Devane, Dysarz, Johnson, Melvin, Howlett, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34, (1988)
[10] Devane, Hanus, Breuer, Pertwee, Stevenson, Griffin, Gibson, Mandelbaum, Etinger, Mechoulam, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, (1992)

← 1 2 3 4 5 →